usually considered vitamins Multi- and mineral supplements are secondary when it comes to brain health, especially in the elderly and the challenge they face in immunizing themselves once morest dementia.
However, a recent American study conducted by Wake Forest University in North Carolina and Brigham Hospital, indicated that taking vitamins (Multivitamins) daily prevents cognitive decline in the elderly.
The study is the first of its kind to prove that it may benefit brain function in aging, according to a report published by the British newspaper “The Guardian” yesterday, Wednesday.
May slow cognitive decline
A trial of more than 2,200 people over 65 found that daily supplements may slow cognitive decline by 60%, or nearly two years, with the most substantial effects seen in older adults with a history of cardiovascular disease.
But while the findings encourage experts in Alzheimer’s disease and dementia, the study cautions that larger studies are needed to confirm the effect before recommending daily multivitamins to help protect older adults from cognitive decline.
expressive (Shutterstock)
They also noted that previous tests of the nutritional supplement had no effect on the disease.
improve cognition
Writing in the journal Alzheimer’s and Dementia, the researchers explain that the study is preliminary evidence in a long-term, randomized trial of women and men that shows that daily use of vitamins and minerals can improve cognition.
They also said that this finding might have important public health implications for brain health and resilience once morest future cognitive decline.
Professor Laura Baker, co-lead researcher on the Cosmos study at Wake Forest University, said it was too early to recommend a daily multivitamin to prevent cognitive decline.
dementia
She added that more research is needed in a larger and more diverse group of people despite the promising results, noting that work is needed to better understand the benefit of multivitamins on cognition in the elderly.
There is no cure for dementia
It is noteworthy that dementia has become one of the leading global health challenges, in light of the lack of drugs that can treat any of the common types.
In the UK, around 850,000 people live with dementia, most of them with Alzheimer’s disease or ‘vascular dementia’.
People over 65, who have diabetes, high blood pressure, high cholesterol and depression, are most at risk.
